LIVESURE COCAINE SCREEN TEST— 510(k) K010967

Name: FDA 510(k) clearance K010967
Creator: U.S. Food and Drug Administration
Published: 2001-04-17

Substantially Equivalent

Pan Probe Biotech, Inc.

FDA 510(k) clearance K010967 for LIVESURE COCAINE SCREEN TEST, Substantially Equivalent on 2001-04-17. Applicant: Pan Probe Biotech, Inc.. Device class: 2.

Clearance details

Applicant: Pan Probe Biotech, Inc.
Product code: Code DIO
Device class: Class 2
Regulation: 21 CFR 862.3250
Advisory panel: Clinical Toxicology
Date received: 2001-04-02
Decision date: 2001-04-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DIO

view all

K213211 — Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System2022-01-27
K211973 — DRI Cocaine Metabolite Assay2021-09-24
K191638 — Pointe Scientific Cocaine Metabolite Enzyme Immunoassay2020-03-12
K181499 — DRI Cocaine Metabolite Assay2018-07-06
K170293 — Emit II Plus Cocaine Metabolite Assay2017-10-25

More clearances from Pan Probe Biotech, Inc.

view all

K020968 — LIVESURE HCG URINARY PREGNANCY TEST STRIP AND TEST CARD2002-07-15
K013796 — LIVESURE METHADONE SCREEN TESTS2001-11-26
K012107 — LIVESURE PHENECYCLINE (PCP) SCREEN TESTS2001-07-20
K012131 — LIVESURE BENZODIAZEPINES SCREEN TESTS2001-07-20
K012133 — LIVESURE BARBITURATES SCREEN TEST2001-07-20

Data sourced from openFDA. This site is unofficial and independent of the FDA.